Drugs | FDA - U.S. Food and Drug Administration
Medication Guides, Drug Safety Communications, Shortages, Recalls. Drug Approvals and Databases . Drugs@FDA, Orange Book, National Drug Code, Recent drug approvals. Drug Development and Review Process
Novel Drug Approvals for 2025 | FDA
2025年2月21日 · No. Drug Name Active Ingredient Approval Date FDA-approved use on approval date* 5. Romvimza: vimseltinib: 2/14/2025: To treat symptomatic tenosynovial giant cell tumor for which surgical ...
Find Information about a Drug - FDA
2022年8月9日 · Find Drug Information on MedlinePlus. Easy-to-use resource from NIH with information about side effects, dosage, special precautions, and more for prescription and OTC drugs
Drug Trials Snapshot: COBENFY - FDA
2025年1月15日 · DRUG TRIALS SNAPSHOT SUMMARY: What is the drug for? COBENFY is a combination of xanomeline, a muscarinic agonist, and trospium chloride, a muscarinic antagonist, and is used for the treatment of ...
drug approvals were approved for rare diseases, including:* • Neimann-Pick disease type C, a genetic disease that results in progressive neurological symptoms and organ dysfunction.
National Drug Code Directory - U.S. Food and Drug Administration
The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs manufactured, prepared, propagated ...
Drug Safety Priorities Fiscal Year 2024, our 10th yearly report covering the fiscal year ending September 30, shows the extensive safety activities conducted by
FDA Proposes Framework to Advance Credibility of AI Models …
2025年1月6日 · The FDA is seeking public comment on the draft guidance, Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products, within 90 ...
General Drug Categories | FDA
Expectorant: A drug that stimulates the flow of saliva and promotes coughing to eliminate phlegm from the respiratory tract.Hormones: Chemicals produced naturally by the endocrine glands (thyroid ...
Novel Drug Approvals for 2024 | FDA
2024年12月20日 · Drug Trials Snapshot: 23. Leqselvi: deuruxolitinib: 7/25/2024: To treat severe alopecia areata Drug Trials Snapshot: 22. Kisunla: donanemab-azbt: 7/2/2024: To treat Alzheimer’s disease Drug ...